Search clinical trials for: Melan-A/Mart-1 peptide

Total 470991 results

Centre Hospitalier Universitaire Vaudois
Ludwig Institute for Cancer Research

Completed

Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients

Melanoma

Switzerland
Centre Hospitalier Universitaire Vaudois
Ludwig Institute for Cancer Research

Completed

Immunotherapy of Stage III/IV Melanoma Patients

Melanoma

Switzerland
Nantes University Hospital

Completed

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Immunotherapy

France
Centre Hospitalier Universitaire Vaudois

Completed

Immunotherapy of Melanoma Patients

Melanoma

Switzerland
University of Lausanne Hospitals
Fond'action contre le cancer; Barletta Foundation; NCCR (National Center of Competence...

Suspended

Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients

Melanoma

Switzerland
Dana-Farber Cancer Institute

Completed

Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma

Melanoma (Skin)

United States
Centre Hospitalier Universitaire Vaudois
Immutep S.A.S.

Terminated

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients (LAG-3/IMP321)

Melanoma

Switzerland
University of Chicago

Completed

Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma

Metastatic Melanoma

United States
European Organisation for Research and Treatment...

Terminated

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Intraocular Melanoma

Belgium, Denmark
Prof. Dr. Silke Gillessen

Terminated

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma

Melanoma

Switzerland
University Hospital, Basel, Switzerland

Completed

Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma

Melanoma

Switzerland
University of Chicago
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Istituto Superiore di Sanità
University of Rome Tor Vergata; Regina Elena Cancer Institute

Completed

Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients (DTIC-melvacc)

Melanoma

Italy
National Cancer Institute (NCI)

Terminated

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Skin Cancer | Metastatic Melanoma

United States
University of Miami
University of Miami Sylvester Comprehensive Cancer Center

Withdrawn

Mohs and Immunofluorescence for Malignant Melanoma In Situ

Lentigo Maligna | Melanoma In Situ

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA Melanoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma

United States
Genzyme, a Sanofi Company

Unknown

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Melanoma (Skin)

United States
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH)

Completed

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Terminated

Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients

Melanoma

United States
Jonsson Comprehensive Cancer Center

Completed

Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

Peptide Vaccination for Patients at High Risk for Recurrent Melanoma

Melanoma

United States
University of Toronto

Completed

Antimicrobial Stewardship in Community Pharmacy

Otitis Media

Canada
Centre for Addiction and Mental Health

Completed

MARt-Depression Trial

Major Depressive Disorder

Canada
University of Texas at Austin
National Institute of Mental Health (NIMH)

Completed

Bringing What Works to Youth in Corrections: A Trauma Intervention

Post-Traumatic Stress Disorder

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Melanoma (Skin)

United States
Çanakkale Onsekiz Mart University

Completed

Mindfulness in Childbirth Preparation Education Process

Pregnant Women

Turkey
University of Waterloo

Completed

Home Medication Reviews by Pharmacists in Ontario, Canada

Medication Therapy Management | Home Care | Pharmacists

Canada
University of Southern California
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Intraocular Melanoma | Melanoma (Skin)

United States
Washington University School of Medicine
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

Study to Understand Risk and Resilience Opportunity for Newborns After Delivery (SURROuND)

A. Longitudinal Cohort n=400 | B. Lower Risk (n=45) and Higher Risk (n=105) Randomized 2:1 to PERCCS Intervention

United States
National Cancer Institute (NCI)

Completed

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Melanoma | Neoplasm Metastasis

United States
Çanakkale Onsekiz Mart University

Recruiting

Predicting Post-op Airway Complications in Pediatric Patients Using Ultrasonography

Airway Complication of Anesthesia

Turkey
Çanakkale Onsekiz Mart University

Completed

Percutaneous Tracheostomy With COVID-19

Tracheostomy

Turkey
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Melanoma | Skin Cancer

United States
National Institute of Allergy and Infectious Diseases...

Completed

Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
Çanakkale Onsekiz Mart University

Completed

Mindfulness Training in Nurses and Its Effect on Work Stress

Nursing Caries | Consciousness, Level Altered

Turkey
ART Medical Ltd.

Terminated

Functionality and Accuracy of the smART System in Real-Life ICU Settings

Aspiration Pneumonia

United States
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact Lenses

Visual Acuity

United States, Hong Kong
Johnson & Johnson Vision Care, Inc.

Completed

Clinical Evaluation of Investigational Contact Lenses

Visual Acuity

Hong Kong
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

Recurrent Melanoma | Stage IV Melanoma | Stage III Melanoma
Coopervision, Inc.

Completed

Comparison of Verofilcon A Daily Disposable Lenses to Somofilcon A Daily Disposable Lenses

Myopia

Canada
Coopervision, Inc.

Completed

Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist

Myopia

United States
University of Zurich
University of Texas Southwestern Medical Center; Swiss Federal Institute of...

Completed

Metabolic Acidosis in Renal Transplant Patients (MART)

Bone Disease | Metabolic Acidosis | Physical Capacity | Renal Transplant Patients | Mineral Metabolism

Switzerland
Coopervision, Inc.

Completed

Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact Lenses

Myopia

United Kingdom
Alcon Research

Completed

Clinical Comparison of Two Daily Disposable Contact Lenses

Refractive Errors

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma

Melanoma (Skin)

United States
Bristol-Myers Squibb
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

Intraocular Melanoma | Melanoma (Skin)

United States

Search clinical trials for: Melan-A/Mart-1 peptide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations